Derivative strategy on Sun Pharma by HDFC Securities

Derivative strategy by Nandish Shah, Senior Technical & Derivative Analyst, HDFC Securities

Trading Strategy
Nandish Shah Mumbai
1 min read Last Updated : Jul 12 2019 | 8:05 AM IST
Bull Spread strategy on Sun Pharma

Buy Sun Pharma July 400 Call at Rs 10; Lot size: 1,100

Target: Rs 420 call at Rs 3.6.

Cost of the strategy Rs 6.4 (Rs 7,040 per strategy)

Maximum profit: Rs 14,960 If Sun Pharma closes at or above 420 on July expiry.

Break-even Point: Rs 406.4

Rationale:

Also Read


Long build-up is seen in the Sun Pharma Futures’ yesterday, where we have seen rise in Open Interest with price rising by 1.5 per cent.
 
Stock price formed double bottom around 367 levels and reversed nothwards to close above its 5 and 20 day SMA.

Oscillators and Momentum Indicators like RSI and MACD showing strength in the stock on the daily and weekly charts.

In the Option segment, we have seen Open Interest addition at 430-440 levels

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Derivative strategies

Next Story